BGI Group (China)

BGI Group (China)

BGI Group is a Shenzhen-based genomics company with links to the Chinese government and military.BGI Group was originally formed in 1999 as a genetics research center to participate in the Human Genome Project. It also sequences genomes of other animals, plants and microorganisms. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BGI Group (China), China, covering academic research published from 2001 to 2021. Read More.


Open Access Percentage

72%


Total
Publications

951


Total Open
Publications

685


Total
Citations

66K


Open Access
Percentage

72%


Total
Publications

951


Total Open
Publications

685


Total
Citations

66K

Wikipedia

Website

download

Breakdown

8% 51% 13% 28%

Publisher Open

8%

Both

51%

Other Platform Open

13%

Closed

28%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

63%OA Journal

OA Journal 63%

352

Hybrid 23%

128

No Guarantees 14%

80

Other Platform Open

Domain 82%

503

Institution 25%

151

Preprint 16%

101

Public 15%

93

Other Internet 11%

69

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
506
Europe PMC
Domain
404
Semantic Scholar
Public
86
bioRxiv
Preprint
79
DOI
Other Internet
55
University of Copenhagen - Research at the University of Copenhagen
Institution
39
Technical University of Denmark, DTU - Technical University of Denmark, DTU Orbit
Institution
25
Research Square
Preprint
16
Ghent University - Ghent University Academic Bibliography
Institution
13
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
13
1 / 14

Data updated 27 September 2022

Share

Share

Share